Related Experiment Videos
Sequelae of caffeine treatment in preterm infants with apnea
Insights
Caffeine treatment for neonatal apnea in low-birth-weight infants reduced mechanical ventilation needs. No significant differences in growth or development were observed between caffeine-exposed and control infants.
Area of Science:
- Neonatal medicine
- Pediatric pharmacology
Background:
- Neonatal apnea is common in low-birth-weight infants.
- Mechanical ventilation is often required for respiratory support.
Purpose of the Study:
- To evaluate the effects of caffeine on growth, neurologic, and ophthalmologic outcomes in low-birth-weight infants with neonatal apnea.
Main Methods:
- A controlled study involving 21 low-birth-weight infants treated with caffeine for neonatal apnea and 21 matched controls.
- Growth, neurologic, and ophthalmologic assessments were conducted.
Main Results:
- Caffeine significantly reduced the need for and duration of mechanical ventilation.
- No significant differences in growth and development were found between groups.
- A high incidence of cicatricial retrolental fibroplasia was noted in both caffeine-treated and control infants.
Conclusions:
- Caffeine is effective in reducing mechanical ventilation in neonates with apnea.
- Caffeine does not appear to adversely affect growth and development.
- Further investigation is needed regarding the high incidence of retrolental fibroplasia.
Abstract:
Growth, neurologic, and ophthalmologic assessments were done in 21 low-birth-weight infants given caffeine for neonatal apnea and in 21 matched control infants. Caffeine significantly decreased the need for and the duration of mechanical ventilation. No difference in growth and development was noted between the control and caffeine-treated infants. A high incidence of cicatricial retrolental fibroplasia was observed in both control (10/21) and caffeine-treated infants (7/18).